eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel
‹‹ Go Back

Qiusheng Chen

Florida State University



‹‹ Go Back

Xu-Feng Niu

Florida State University



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

295 – Adaptive Designs and Interim Analyses

Tests and Classifications in Adaptive Designs with Applications

Sponsor: Biopharmaceutical Section
Keywords: Adaptive Designs, Biomarker Identification, Classification Methods, Sensitive Genes, Sensitive Patients

Qiusheng Chen

Florida State University

Xu-Feng Niu

Florida State University

Statistical tests for biomarker identification and classification methods for patients grouping are two important topics in adaptive designs of clinical trials. In this article, we evaluate three test methods for biomarker identification: a model-based identification method, the popular t-test, and the nonparametric Wilconxon Rank Sum test. For selecting the best classification methods in Stage 2 of an adaptive design, we examine classification methods including the recent developed machine learning approaches such as Random Forest, the Lasso and Elastic-Net Regularized Generalized Linear Models (Glmnet) , Support Vector Machine (SVM), the Gradient Boosting Machine (GBM), and the Extreme Gradient Boosting (XGBoost). Statistical simulations are carried out in our study to assess the performance of biomarker identification methods and the classification methods. The best identification method and the classification method will be selected based on the True Positive Rate (TPR) and the False Positive Rate (FPR). The optimal test method for gene identification and classification method for patients grouping will be applied to the Adaptive Signature Design (ASD) for the purpose of evalua

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2017 CadmiumCD